Survival
74
8
8
32
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.4%
1 terminated out of 74 trials
97.0%
+10.5% vs benchmark
14%
10 trials in Phase 3/4
0%
0 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (74)
Low-dose Dexmedetomidine and Postoperative Delirium After Cardiac Surgery
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Changes in Body Composition of Patients With Obesity Related Tumors and Their Impact on Clinical Outcomes: a Multicenter Prospective Cohort Study
Nutritional Intervention and Outcomes in Elderly After Hip Fracture Surgery
Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study
Intradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients
Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Incremental PD With Single Icodextrin Exchange
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
Abdominal or Transanal TME for Rectal Cancer Therapy
Retrospective Analysis of De-identified Deceased HCC Patients
The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy
Metabolic Syndrome and Long-term Survival Following Liver Resection
French Single Centre Experience of Critically Ill Patients With Covid 19
Telerehabilitation in Survival Breast Cancer Patients
Outcomes and Prognostic Factors in COVID-19